These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6973342)

  • 1. Potentiation of 1-beta-D-arabinofuranosylcytosine in hepatoma cells by 2'-deoxyadenosine or 2'-deoxyguanosine.
    Harkrader RJ; Boritzki TJ; Jackson RC
    Biochem Pharmacol; 1981 May; 30(10):1099-104. PubMed ID: 6973342
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential combination of methotrexate and 1-beta-D-arabinofuranosylcytosine shows synergistic effect on the generation of DNA strand breaks in a human promyelocytic leukemia cell line.
    Tanizawa A; Kubota M; Takimoto T; Kito T; Akiyama Y; Kiriyama Y; Mikawa H
    Adv Exp Med Biol; 1989; 253B():349-54. PubMed ID: 2610122
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 3'deoxyadenosine (cordycepin) and 2'deoxyadenosine on nucleoside transport, macromolecular synthesis, and replication of cultured Novikoff hepatoma cells.
    Plagemann PG
    Arch Biochem Biophys; 1971 May; 144(1):401-12. PubMed ID: 4330131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of deoxyadenosine on nucleic acid synthesis by tumor cells in the presence of a deaminase inhibitor].
    Vornovitskaia GI; Ioannesiants IA; Borzenko BG; Shapot VS
    Vopr Med Khim; 1975; 21(2):192-5. PubMed ID: 166514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of ochratoxin A on cultured hepatoma cells--reversion of inhibition by phenylalanine.
    Creppy EE; Lugnier AA; Beck G; Röschenthaler R; Dirheimer G
    FEBS Lett; 1979 Aug; 104(2):287-90. PubMed ID: 477989
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the inhibition of DNA synthesis by deoxyadenosine in tumor cells].
    Vornovitskaia GI; Ol'shanetskaia AD; Novikova MA; Karelina LP; Morozova NS
    Biokhimiia; 1972; 37(5):940-7. PubMed ID: 4344203
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S; Lehman C; Cadman E
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract]   [Full Text] [Related]  

  • 8. Transport and metabolism of deoxycytidine and 1-beta-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis.
    Plagemann PG; Marz R; Wohlhueter RM
    Cancer Res; 1978 Apr; 38(4):978-89. PubMed ID: 205355
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracellular conversions of deoxyribonucleosides by Novikoff rat hepatoma cells and effects of hydroxyurea.
    Plagemann PG; Erbe J
    J Cell Physiol; 1974 Jun; 83(3):321-36. PubMed ID: 4363878
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of thymidine in biochemical modulation: a review.
    O'Dwyer PJ; King SA; Hoth DF; Leyland-Jones B
    Cancer Res; 1987 Aug; 47(15):3911-9. PubMed ID: 3300957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S; Bhalla K; Rauscher F; Cadman E
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced DNA damage induced in human melanoma cells by dacarbazine in the presence of deoxyribonucleosides.
    Lönn U; Lönn S; Nylen U; Winblad G
    Cancer Res; 1989 Jun; 49(11):2921-4. PubMed ID: 2785848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
    Chou TC; Arlin Z; Clarkson BD; Phillips FS
    Cancer Res; 1977 Oct; 37(10):3561-70. PubMed ID: 332337
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosine.
    Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
    Biochem Pharmacol; 1984 Apr; 33(7):1059-63. PubMed ID: 6712715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I; Saito S; Hori K; Suzuki M; Sato H
    Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
    Neil GL; Buskirk HH; Moxley TE; Manak RC; Kuentzel SL; Bhuyan BK
    Biochem Pharmacol; 1971 Dec; 20(12):3295-308. PubMed ID: 5002403
    [No Abstract]   [Full Text] [Related]  

  • 17. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
    Ross DD; Akman SA; Joneckis CC; Yang E; Bachur NR
    Cancer Res; 1984 Apr; 44(4):1530-5. PubMed ID: 6584206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
    Ashman CR; Kaufman ER; Davidson RL
    Basic Life Sci; 1985; 31():391-408. PubMed ID: 3888181
    [No Abstract]   [Full Text] [Related]  

  • 19. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells.
    Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
    Cancer Treat Rep; 1985; 69(7-8):851-7. PubMed ID: 4016794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine.
    Dahbo Y; Eriksson S
    Eur J Biochem; 1985 Aug; 150(3):429-34. PubMed ID: 3874778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.